Showing 22,001 - 22,020 results of 25,042 for search '"CD"', query time: 0.12s Refine Results
  1. 22001

    Treatment Effect of a Vascular-Disrupting Agent Dynamically Monitored by DWI: An Animal Experimental Study by Danping Huang, Ruimeng Yang, Yong Zou, Hongmei Lin, Xiangdong Xu, Xinhua Wei, Hanzheng Chang, Liqiong Wu, Wenshuang Ding, Wenjie Tang, Xinqing Jiang

    Published 2021-01-01
    “…Two randomly chosen rabbits from each group were sacrificed for H&E staining and CD34 immunohistochemical assessments at each time point. …”
    Get full text
    Article
  2. 22002
  3. 22003
  4. 22004
  5. 22005

    Mouse Models of Nonalcoholic Steatohepatitis: Head-to-Head Comparison of Dietary Models and Impact on Inflammation and Animal Welfare by Andreas Kroh, Vanina Ivanova, Hannah Drescher, Julia Andruszkow, Thomas Longerich, Jochen Nolting, Roman Eickhoff, D. Heise, Karl P. Rheinwalt, Ulf P. Neumann, Florian T. Ulmer

    Published 2020-01-01
    “…Furthermore, the progression of inflammation and liver fibrosis was associated with a decreased proportion of CD3+ NK1.1+ cells. The WD represents a model of advanced-stage NASH, and the HFD60 is a strong model of nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome. …”
    Get full text
    Article
  6. 22006
  7. 22007
  8. 22008
  9. 22009
  10. 22010
  11. 22011
  12. 22012
  13. 22013

    B7-H4 Pathway in Islet Transplantation and β-Cell Replacement Therapies by Xiaojie Wang, Jianqiang Hao, Daniel L. Metzger, Ziliang Ao, Mark Meloche, C. Bruce Verchere, Lieping Chen, Dawei Ou, Alice Mui, Garth L. Warnock

    Published 2011-01-01
    “…More importantly, B7-H4 plays an indispensable role in alloimmunity in the absence of the classic CD28/CTLA-4 : B7 pathway, suggesting a synergistic/additive effect with other agents such as CTLA-4 on inhibition of unwanted immune responses.…”
    Get full text
    Article
  14. 22014
  15. 22015
  16. 22016
  17. 22017
  18. 22018
  19. 22019
  20. 22020